Derek Lowe has another theory: http://pipeline.corante.com/archives/2014/11/06/what_happens_after_your_first_drug_approval.php http://pipeline.corante.com/archi

Derek Lowe has another theory: http://pipeline.corante.com/archives/2014/11/06/what_happens_after_your_first_drug_approval.php http://pipeline.corante.com/archives/2014/11/06/what_happens... Your average startup brings exactly one drug to market, and then is aquired and broken up. The current system does not encourage building institutional experience in the field, in fact it destroys it.